Compare Airbnb, Inc. (ABNB) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Airbnb, Inc. vs Amphastar Pharmaceuticals Inc — how do they compare? Airbnb, Inc. trades at $184.98 (market cap $110.60B), while Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M). The key difference: Airbnb, Inc. is far larger — about 128× Amphastar Pharmaceuticals Inc's market cap, and Airbnb, Inc. is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ABNB | AMPH | |
|---|---|---|
Market Cap | $110.60B | $863.95M |
Sector | Consumer Cyclical | Health |
52-Week High | $184.70 | $30.81 |
52-Week Low | $111.54 | $16.87 |
Enterprise Value | $101.02B | $1.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Airbnb (ABNB) is trading at $178.07, up 17.43% with strong momentum after Q2 2026 earnings beat expectations. The stock is approaching four-year highs with bullish technical indicators and positive analyst sentiment. Revenue growth accelerated to $12.24B in 2025 with robust 82.9% gross margins, though recent quarters showed mixed earnings performance with two misses and one beat.
Outlook remains positive with AI-driven growth initiatives and expanding service offerings, but elevated valuation multiples (P/E 40.66) and competitive pressures present risks. Analyst consensus leans bullish with 46.7% buy ratings and $173.26 price target, though current price exceeds consensus target by 2.8%.
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Airbnb, Inc.
Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.
Read more on ABNB →About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →
